NCT07635329 Home-based Vision Rehabilitation Guided by Brain Imaging
| NCT ID | NCT07635329 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Georgetown University |
| Condition | Visual Field Defect |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2030-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-07-01 with a primary completion date of 2030-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The BRIGHT (Behavioral Rehabilitation Through Image-Guided Home-based Training) study aims to evaluate the effectiveness of image-guided, home-based perceptual training at improving visual performance in individuals with visual field loss. Using a prospective, crossover design, BRIGHT combines visual behavioral testing, neuroimaging, and a home-based intervention. It aims to 1) identify neural pathways that support training-induced visual plasticity; and 2) compare the efficacy of different types of visual training delivered in a home-based setting.
Eligibility Criteria
Inclusion Criteria: 1. At least 18 years of age. 2. Capable of providing informed consent and complying with study procedures. 3. Unilateral or bilateral focal brain damage causing visual field loss. 4. At least three months post-stroke or traumatic brain injury, or a stable brain tumor within the past year. 5. Eligible for MRI based on standard safety screening. Exclusion Criteria: 1. Severe neurological or psychiatric conditions unrelated to the focal lesion that may interfere with study participation or data interpretation. 2. Current or recent (within the past 6 months) drug or alcohol abuse or addiction as defined by DSM-5. 3. Ocular disease or disorder.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07635329 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Visual Field Defect. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07635329 currently recruiting?
Yes, NCT07635329 is actively recruiting participants. Contact the research team at tina.liu@georgetown.edu for enrollment information.
Where is the NCT07635329 trial being conducted?
This trial is being conducted at Washington D.C., United States.
Who is sponsoring the NCT07635329 clinical trial?
NCT07635329 is sponsored by Georgetown University. The trial plans to enroll 100 participants.